Era of ‘Free’ Covid Vaccines, Test Kits, and Treatments Is Ending. Who Will Pay the Tab Now?
Insurers, employers, and taxpayers will all be affected as drug manufacturers move these products to the commercial market.
KFF Health News' 'What the Health?': Au Revoir, Public Health Emergency
The Biden administration this week announced it would let the covid-19 public health emergency lapse on May 11, even as the Republican-led House was voting to immediately eliminate the special authorities of the so-called PHE. Meanwhile, anti-abortion forces are pressuring legislators to both tighten abortion restrictions and pay for every birth in the nation. Margot Sanger-Katz of The New York Times, Rachel Roubein of The Washington Post, and Victoria Knight of Axios join KHN’s chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Hannah Wesolowski of the National Alliance on Mental Illness about the rollout of the national 988 suicide prevention hotline.
Watch: Covid Increases Risk of Heart Problems, New Data Underlines
Céline Gounder, KHN editor-at-large for public health, discusses new data showing an excess of deaths in 2020 related to heart disease.
FDA Experts Are Still Puzzled Over Who Should Get Which Covid Shots and When
A single booster seems to prevent death and hospitalization in most people, but protection from the current vaccines wanes within months. FDA experts say they need to know more from the Centers for Disease Control and Prevention to decide the best long-term strategy.
Florida Gov. DeSantis Falsely Claims Bivalent Booster Boosts Chances of Covid Infection
Experts say the Florida governor’s conclusion could not be drawn from the study he cited, adding that the research focused on health care workers, who are likelier to be exposed to covid and more likely to be vaccinated. Those findings should not be applied to the general public.
Latino Teens Are Deputized as Health Educators to Sway the Unvaccinated
Some community health groups are training Latino teens to conduct outreach and education, particularly in places where covid vaccine fears linger.
Adolescentes latinos se entrenan para educar sobre las vacunas contra covid
Organizaciones comunitarias de salud en California y en todo el país forman a adolescentes, muchos de ellos latinos, para que actúen como educadores de la salud en la escuela, en las redes sociales y en las comunidades donde persiste el miedo a la vacuna contra covid.
Readers and Tweeters Diagnose Greed and Chronic Pain Within US Health Care System
KHN gives readers a chance to comment on a recent batch of stories.
Lo que necesitan saber los adultos mayores sobre covid y Paxlovid
Expertos dicen que la terapia de primera elección debe ser Paxlovid, un tratamiento antiviral para personas con covid leve a moderado con alto riesgo de enfermarse gravemente.
What Older Americans Need to Know About Taking Paxlovid
Covid-19 continues to hit seniors with disproportionate severity. Experts say Paxlovid is an effective therapy that is being underprescribed for people 65 and older.
Public Health Agencies Try to Restore Trust as They Fight Misinformation
As public health departments work on improving their message, the skepticism and mistrust often reserved for covid-19 vaccines now threaten other public health priorities, including flu shots and childhood vaccines.
KHN’s ‘What the Health?’: The Covid Response Coordinator Speaks
In this special episode of KHN’s “What the Health?” Dr. Ashish Jha, the White House coronavirus response coordinator, talks with host Julie Rovner, KHN’s chief Washington correspondent, about where we are in the pandemic and how we should transition out of the public health emergency. This episode was taped on Dec. 20.
Inmigrantes detenidos en centros enfrentan riesgo de covid como al inicio de la pandemia
Para las aproximadamente 30,000 personas que viven en espacios cerrados en la red de instalaciones de detención de inmigrantes del país, covid sigue siendo una amenaza constante.
‘Caged … For No Fault of Your Own’: Detainees Dread Covid While Awaiting Immigration Hearings
Covid remains a threat for the roughly 30,000 people in the country’s network of immigration facilities. But ICE continues to flout its own pandemic protocols, an extension of the facilities’ poor history of medical care.
A Retiree Returns to Work After a Calamitous Year of Health Emergencies
In 2020, diabetes and covid-19 landed David Zipprich in the hospital three times. Even with insurance, he was inundated with bills, debt notices, and calls from collectors.
Readers and Tweeters Chime In on Disability Rights and Drug Discounts
KHN gives readers a chance to comment on a recent batch of stories.
KHN’s ‘What the Health?’: Health Spending? Only Congress Knows
Top negotiators in Congress have agreed to a framework for government spending into next year, but there are details to iron out before a vote — such as the scheduled Medicare payment cuts that have providers worried. Also, the Biden administration reopens its program allowing Americans to request free covid-19 home tests, as hopes for pandemic preparedness measures from Congress dim. Rachel Cohrs of Stat, Alice Miranda Ollstein of Politico, and Rebecca Adams of KHN join KHN’s Mary Agnes Carey to discuss these topics and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
Paxlovid Has Been Free So Far. Next Year, Sticker Shock Awaits.
The government soon will stop paying for the covid drug that has proved to be the most effective at keeping patients alive and out of the hospital.
Para lanzar un nuevo fármaco al mercado, la Administración de Alimentos y Medicamentos (FDA) exige a las farmacéuticas estudios exhaustivos para demostrar su seguridad y eficacia. Conseguir que un medicamento salga al mercado unos meses antes, y con menos gastos de lo habitual, puede traducirse en beneficios millonarios para el fabricante.
The Business of Clinical Trials Is Booming. Private Equity Has Taken Notice.
Private equity-backed Headlands Research heralded its covid-19 vaccine trials as a chance to boost participation among diverse populations, then it shuttered multiple sites that conducted them.
